Immunophenotype of adult and childhood acute lymphoblastic leukemia: Changes at first relapse and clinico-prognostic implications

Leukemia

Volumn 11, Issue 9, 1997, Pages 1501-1507

  Guglielmi, C ^a,c   Cordone, I ^a   Boecklin, F ^a   Masi, S ^a   Valentini, T ^a   Vegna, M L ^a   Ferrari, A ^a   Testi, A M ^a   Foa, R ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Cattedra di Ematologia   (Italy)

Author keywords

Immunophenotype; Leukemia; Lymphoblastic; Relapse

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; CD19 ANTIGEN; CD33 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; MICROSOMAL AMINOPEPTIDASE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; B CELL LEUKEMIA; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA REMISSION; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; T CELL LEUKEMIA;

EID: 0030773268     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400772     Document Type: Article

References (25)

1. Borella C, Casper JT, Lauer SJ, Shifts in expression of cell membrane phenotypes in childhood lymphoid malignancies at relapse. Blood 1979; 54: 64-71.
2. Greaves M, Paxton A, Janossy G, Pain C, Johnson S, Lister TA. Acute lymphoblastic leukemia associated antigen. III Alterations in expression during treatment and in relapse. Leukemia Res 1980; 4: 1-14.
3. Lauer S, Piaskowsky V, Camitta B, Casper J. Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse. Leukemia Res 1982; 6: 769-774.
4. Pui CH, Raimondi SC, Behm FG, Ochs J, Furman WL, Binin NJ, Ribeiro RC, Tinsley PA, Mirro J. Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia. Blood 1986; 68: 1306-1308.
5. Abshire TC, Buchanan GR, Jackson JF, Shuster JJ, Brock B, Head D, Behm F, Crist WM, Link M, Borowitz M, Pullen J. Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study. Leukemia 1992; 6: 357-362.
6. Raghavachar A, Thiel E, Bartram CR. Analyses of phenotype and genotype in acute lymphoblastic leukemias at first presentation and in relapse. Blood 1987; 70: 1079-1083.
7. van Wering ER, Beishuizen A, Roeffen ETJM, van der Linden-Schrever BE, Verhoeven M-AJ, Hahlen K, Hooijkaas H, van Dongen JJM. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia. Leukemia 1995; 9: 1523-1533.
8. Pui CH, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud HM, Sandlund JT, Crist WM. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. New Engl J Med 1991; 352: 1682-1687.
9. Ratain MJ, Rowley JD. Therapy related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from bedside to target genes. Ann Oncol 1992; 3: 107-111.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. The morphologic classification of acute lymphoblastic leukemia: concordance among observers and clinical correlations. Br J Haematol 1981; 47: 553-558.
11. Catovsky D, Matutes E, Buccheri V, Hanslip J, Yoshida N, Morilla R. A classification of acute leukemia for the 1990s. Ann Hematol 1991; 62: 16-21.
12. De Rossi G, Grossi C, Foà R, Tabilio A, Vegna L, Lo Coco F, Annino L, Camera A, Cascavilla N, Ciolli S, Del Poeta G, Liso V, Mandelli F. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (GIMEMA). Leuk Lymphoma 1993; 9: 221-228.
13. Hurwitz CA, Mirro J. Mixed-lineage leukemia and asyncronous antigen expression. Hematol Oncol Clin North Am 1990; 4: 767-794.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
15. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Cox DR. Regression models and life tables. J Roy Stat Soc B 1972; 34: 187-220.
17. Campana D, Coustan-Smith E, Janossy G. The immunological detection of minimal residual disease in acute leukemia. Blood 1990; 76: 163-171.
18. Saito M, Kumagai M, Okazaki J, Nakazawa S, Shapiro LH, Look AT, Campana D. Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells. Leukemia 1995; 9: 1508-1516.
19. Bradstock KF, Janossy G, Tidman N, Papageorgiou ES, Prentice HG, Willoughby M, Hoffbrand AV. Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukemia. Leukemia Res 1981; 5: 301-309.
20. Van Dongen JJM, Breit TM, Adrianseen HJ, Beishizen A, Hooijkaas H. Detection of minimal residual disease in acute leukemia by immunological markers analysis and polymerase chain reaction. Leukemia 1992; 6 (Suppl. 1): 47-52.
21. Basso G, Putti MC, Cantù-Rajnoldi A, Saitta M, Santostasi T, Santoro N, Lippi A, Comelli A, Felici L, Favre C, Russo Mancuso G, Guglielmi C, Paolucci P, Biondi A, Rondelli R, Pession A. The immunophenotype in infant acute lymphoblastic leukemia: correlation with clinical outcome. An Italian multicentre study (AIEOP). Br J Haematol 1992; 81: 184-191.
22. De Rossi G, Aloe Spiriti MA, Cafolla A, Gastaldi R, Lo Coco F, Lopez M, Luciani M, Pasqualetti D, Testi AM, Mandelli F. CALLA-negative, TdT- and CD7-positive acute lymphoblastic leukemia: a phenotype associated with poor prognosis. Diagn Clin Immunol 1987; 5: 140-143.
23. Cimino G, Lo Coco F, Biondi A, Elia L, Luciano A, Croce CM, Masera C, Mandelli F, Canaani E. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood 1993; 82: 544-546.
24. Chen CS, Sorensen PHB, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond CD, Kersey GH. Molecular rearrange-ments on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993; 81: 2386-2393.
25. Cimino G, Rapanotti MC, Rivolta A, Lo Coco F, D'Arcangelo E, Rondelli R, Basso G, Barisone E, Rosanda C, Santostasi T, Canaani E, Masera G, Mandelli F, Biondi A. Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemia. Leukemia 1995; 9: 391-395.